Proteogenomic Characterization of Endometrial Carcinoma

the Clinical Proteomic Tumor Analysis Consortium

研究成果: 雜誌貢獻期刊論文同行評審

254 引文 斯高帕斯(Scopus)


We undertook a comprehensive proteogenomic characterization of 95 prospectively collected endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This analysis revealed possible new consequences of perturbations to the p53 and Wnt/β-catenin pathways, identified a potential role for circRNAs in the epithelial-mesenchymal transition, and provided new information about proteomic markers of clinical and genomic tumor subgroups, including relationships to known druggable pathways. An extensive genome-wide acetylation survey yielded insights into regulatory mechanisms linking Wnt signaling and histone acetylation. We also characterized aspects of the tumor immune landscape, including immunogenic alterations, neoantigens, common cancer/testis antigens, and the immune microenvironment, all of which can inform immunotherapy decisions. Collectively, our multi-omic analyses provide a valuable resource for researchers and clinicians, identify new molecular associations of potential mechanistic significance in the development of endometrial cancers, and suggest novel approaches for identifying potential therapeutic targets.

頁(從 - 到)729-748.e26
出版狀態已出版 - 20 2月 2020


深入研究「Proteogenomic Characterization of Endometrial Carcinoma」主題。共同形成了獨特的指紋。